Evaluation of a novel PVC and PAC detection algorithm in an implantable cardiac monitor for longitudinal risk monitoring

Marmerstein, Joseph; Reddy, Ravi; Whittington, R. Hollis; Dukes, Jonathan

doi:10.1016/j.hroo.2023.06.001

Cited by 1 publication

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, CIED provide a long-lasting monitoring by an automated PVC count algorithm that may overestimate PVC burden in case of coexistent AF or intermittent atrial undersensing. In a monocentric study, when CIEDs (PM and ICD) were compared to an ambulatorial monitoring they showed a poor sensitivity (0.16) but a high specificity (0.99) in detecting PVCs [67]. A sub analysis of the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) demonstrated the link between the overall burden of premature contractions (both atrial and ventricular) and subsequent low percentage of biventricular pacing with lower rate of reverse remodeling, worsening of HF, death and ventricular tachyarrhythmias [68].…”

Section: Ventricular Arrhythmiasmentioning

confidence: 99%

Contemporary Advances in Cardiac Remote Monitoring: A Comprehensive, Updated Mini-Review

Preda,

Falco,

Tognola

et al. 2024

Medicina

View full text Add to dashboard Cite

Over the past decade, remote monitoring (RM) has become an increasingly popular way to improve healthcare and health outcomes. Modern cardiac implantable electronic devices (CIEDs) are capable of recording an increasing amount of data related to CIED function, arrhythmias, physiological status and hemodynamic parameters, providing in-depth and updated information on patient cardiovascular function. The extensive use of RM for patients with CIED allows for early diagnosis and rapid assessment of relevant issues, both clinical and technical, as well as replacing outpatient follow-up improving overall management without compromise safety. This approach is recommended by current guidelines for all eligible patients affected by different chronic cardiac conditions including either brady- and tachy-arrhythmias and heart failure. Beyond to clinical advantages, RM has demonstrated cost-effectiveness and is associated with elevated levels of patient satisfaction. Future perspectives include improving security, interoperability and diagnostic power as well as to engage patients with digital health technology. This review aims to update existing data concerning clinical outcomes in patients managed with RM in the wide spectrum of cardiac arrhythmias and Hear Failure (HF), disclosing also about safety, effectiveness, patient satisfaction and cost-saving.

show abstract

Section: Ventricular Arrhythmiasmentioning

confidence: 99%